Skin Diseases  >>  pimecrolimus topical  >>  Phase 3
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pimecrolimus topical / Generic mfg.
NCT00351052: Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis

Completed
3
184
Europe
Pimecrolimus, Elidel, Placebo
Novartis
Atopic Dermatitis
 
09/04
NCT00226707: Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand Dermatitis

Completed
3
652
US
Pimecrolimus Cream 1%, Elidel
Novartis
Chronic Hand Dermatitis
 
03/05
NCT00232011: Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis

Completed
3
160
Japan
Pimecrolimus Cream 1%, Elidel
Novartis
Atopic Dermatitis
 
05/05
NCT00231998: Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis

Completed
3
240
Japan
Pimecrolimus, Elidel
Novartis
Atopic Dermatitis
 
06/05
NCT00232115 / 2005-002058-23: Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis

Completed
3
124
Europe
Pimecrolimus, Elidel, Placebo
Novartis
Perioral Dermatitis
 
07/06
NCT00130572: Efficacy of Elidel Cream on Erosive Oral Lichen Planus

Completed
3
20
Europe
Pimecrolimus
University Hospital Tuebingen
Lichen Planus, Oral
12/07
12/07

Download Options